Enzyme News and Research

RSS

Tilarginine does not reduce risk of death after heart attack

The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.

2 Apr 2007

Long-term low to moderate doses of aspirin beneficial for women

Women who take low to moderate doses of aspirin have a reduced risk of death from any cause, and especially heart disease related deaths, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

2 Apr 2007

Gender differences and skin cancer

Inherent gender differences – instead of more sun exposure – may be one reason why men are three times more likely than women to develop certain kinds of skin cancer, say researchers at Ohio State University Medical Center.

2 Apr 2007

New insights into melatonin production

In the April 1 issue of G&D, a Korean research team led by Dr. Kyong-Tai Kim (Pohang University) describes how melatonin production is coordinated with the body's natural sleep/wake cycles.

2 Apr 2007

Glyoxalase I protects proteins against damage by oxidation and nitration

Protein degradation and malfunction is a major cause of ageing and can be the result of attacks on proteins by other molecules.

2 Apr 2007

Effect of gender on the development of UVB-induced skin cancers

Inherent gender differences "instead of more sun exposure" may be one reason why men are three times more likely than women to develop certain kinds of skin cancer, say researchers at Ohio State University Medical Center.

2 Apr 2007

Estrogen improves host response after traumatic injury

Researchers have identified the receptor pathway used by estrogen to decrease liver injury after trauma and hemorrhage.

2 Apr 2007

Natural mechanism for immune suppression may lead to new cancer drugs

A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.

31 Mar 2007

New treatments and interventions for chronically impaired cardiac patients

Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients.

30 Mar 2007

Genetic culprits of idiopathic pulmonary fibrosis

Scientists at Johns Hopkins have identified the genetic culprits that trigger a hereditary form of a fatal lung disease.

30 Mar 2007

New cardiovascular treatment approaches

In an era of increasing death and illness from heart and blood vessel disease - which also can impair kidney function - Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.

30 Mar 2007

Blood pressure control with Clevidipine

Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.

30 Mar 2007

Brain's immune system plays protective role in early Alzheimer's disease

The immune system's response against amyloid-beta, the protein that forms plaques in the brains of patients with Alzheimer's disease, appears to protect the brain from damage in early stages of the devastating neurological disorder.

30 Mar 2007

DNA layer reduces risk of reserve parts being rejected

Dutch researchers Jeroen van den Beucken and John Jansen have given body implants a DNA layer. This layer ensures a better attachment, more rapid recovery of the surrounding tissue and less immune responses. The older we get the more 'reserve-parts' we need.

27 Mar 2007